Viridian Therapeutics, Inc./DE Public Float
Viridian Therapeutics, Inc./DE (VRDN) had Public Float of $943.00 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $943.00M.
- 2024-06-28: Entity Public Float $731.80M.
- 2023-06-30: Entity Public Float $1.02B.
- 2022-06-30: Entity Public Float $329.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $943.00M 10-K · filed 2026-02-26 |
| 2024-06-28 | $731.80M 10-K · filed 2025-03-03 |
| 2023-06-30 | $1.02B 10-K · filed 2024-02-27 |
| 2022-06-30 | $329.30M 10-K · filed 2023-03-09 |
| 2021-06-30 | $157.40M 10-K · filed 2022-03-11 |
| 2020-06-30 | $58.50M 10-K · filed 2021-03-26 |
| 2019-06-28 | $56.50M 10-K · filed 2020-03-13 |
| 2018-06-29 | $165.50M 10-K · filed 2019-03-14 |
| 2017-06-30 | $122.40M 10-K · filed 2018-03-15 |
| 2016-06-30 | $3.40M 10-K · filed 2017-03-24 |
| 2015-06-30 | $11.60M 10-K · filed 2016-03-21 |
| 2014-06-30 | $10.90M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |